Navigation Links
Rutgers scholar authors definitive biography of reproductive medicine pioneer
Date:10/17/2008

CAMDEN As Louise Brown the first baby conceived by in vitro fertilization celebrates her 30th birthday in 2008, a new book coauthored by a Rutgers medical historian offers the first comprehensive insight into the influence of John Rock, the Harvard-affiliated gynecologist and pioneering researcher, in shaping the field of modern reproductive medicine.

Rock was the first researcher to fertilize a human egg in vitro in the 1940s and the co-developer of the first oral contraceptive a decade later. His groundbreaking studies of the human embryo, tracing the path from ovulation to implantation in the uterus, provided the first visual record of the earliest stages of pregnancy.

A new book by Margaret Marsh, distinguished professor of history and interim chancellor at Rutgers UniversityCamden, and her sister, Wanda Ronner, a clinical associate professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, closely examines Rock's 50-year career. His work defined the reproductive revolution, with its twin symbols of the birth control pill and technologically assisted reproduction.

Their collaboration, "The Fertility Doctor: John Rock and the Reproductive Revolution" (John Hopkins University Press, 2008), is the first full-scale historical biography of Rock, who began his working life as a time-keeper on a banana plantation in Guatemala, later became the nation's leading figure in the treatment of infertility, and ended his career as perhaps the world's most recognized advocate for the birth control pill.

"He was the leading clinician in the field of reproductive medicine before the field even had a name," Marsh explains. "We were fascinated by him. We thought he deserved a serious biography."

The authors found Rock's personal story compelling as well. In the 1930s, he was the only Catholic doctor in Massachusetts to support the repeal of a Massachusetts law that prohibited the use of birth con
'/>"/>

Contact: Mike Sepanic
msepanic@camden.rutgers.edu
856-225-6026
Rutgers University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Rutgers Genetics receives $7.8 million for autism research
2. Rutgers high school outreach gets $3 million boost from NSF
3. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
4. Rutgers scientists research reveals critical knowledge about the nervous system
5. USDA Cooperative Agreement funds mosquito project at Rutgers
6. Raydiance collaborates with Rutgers, MTF to develop innovative tissue processing approaches
7. Better protection for biomedial devices could result from Rutgers-Camden research
8. Rutgers biologist to study worms in Amazon, glaciers
9. $3.2M for Rutgers to apply biology, engineering, physical sciences toward stem cells
10. No helicopter moms among Rutgers mutant mice
11. UM coral scientist Peter Glynn wins award for scholarly activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., Preliminary Press Conference Topics, Last Cal...ces museum, Attention PIOs: Sending Press Releas...ration deadline 10 December, News Media registra...pre-registration deadline THIS MONDAY, 7 December,...regarding visas for international reporters, pleas...
(Date:12/3/2009)...by a social snubbing? Your genetics, not your frie...wn that opium-like painkillers, called opioids, re...of emotional stress. Now, a new study reviewed by ... that small genetic differences in the gene for th...eople,s responses to social rejection. , In the...
(Date:12/3/2009)...tic snowmelt that occurred during the 2008-09 aust...itive phases for two main climate drivers, ENSO (E...misphere Annular Mode), according to Dr. Marco Ted...ciences at The City College of New York. , Pro...y at the CUNY Graduate Center, added that Antarcti...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6CCNY professor foresees rising Antarctic snowmelt 2UCF Athletes Set Example While Getting Protected Against Flu 58583 1UCF Athletes Set Example While Getting Protected Against Flu 58583 2Delayed First Visit to Dentist Can Affect Childrens Lifelong Oral Health 58581 1Delayed First Visit to Dentist Can Affect Childrens Lifelong Oral Health 58581 2Private Care Association of Floridas Elects Jim Mark as Vice President 58579 1Private Care Association of Floridas Elects Jim Mark as Vice President 58579 2
...n University] Leading academics and practitioners... latest advances in bioengineering research and na... from ink jets and a new, injectable method for re... Brown University April 4-6, 2008. , It is the fi...t Bioengineering Conference, which will take place...
...rean delivery for their first child go on to have ...aditional way. This is shown in a study from the N...versity of Bergen. , Researchers at the NIPHs Med...ave collected data on all first-time births from 1...vers nearly 600 000 births, so the results are sta...
...er to saving the Earth from global warming lie in ...le University aims to design soils that can remove...effectively. This has never previously been attemp...unded by the Engineering and Physical Sciences Res...iative exploits the fact that plants, crops and tr...
Other Biology News:Brown hosts regional bioengineering conference 2Fewer babies born after Caesarean delivery 2Specially-designed soils could help combat climate change 2
(Date:12/2/2009)...E, Gabon, December 2 , - ...blem and Heritage" , Coinciding with the ...the,Gabonese Republic is hosting an international ...afeguarding biological resources in Africa. The,co...leaders, ministers,scientific experts, private co...
(Date:12/2/2009)...E, Mass., Dec. 2 TechConnect World...logy development and product integration in cleant...ember 11th deadline for technology abstracts and b... TechConnect World, in association with the Nano S...ean Technology and Sustainable Industries Organiza...
(Date:12/2/2009)...E, Dec. 2 S*BIO Pte Ltd today anno...hibitor, SB1518, at The American Society of Hemato...eans. ,, Data will be presented on the clinical... SB1518 detailing its safety, tolerability and pha...se levels ranging from 100 to 600 mg. These doses ...
(Date:12/2/2009)..., China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharm...: SCR ), a leading pharmaceutical company,specia...eting of branded,generic and proprietary pharmaceu...rugs have been included in China,s National Drug R...ina,s Ministry of Human Resources and Social,Secur...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...eneCopoeia announces the launch of a suite of miRN...lude 1) miExpress(TM) vector based precursor miRNA...equence (3, UTR) expression clones; and 3) All-in-...a lentiviral vector system, miExpress(TM) precurs...nown miRNAs for human (750), mouse (450), and rat ...
...scheduled for March 12, 2009 , , NEW YORK, March... ) today announced that it received a letter from ...at the Company had failed to regain compliance wit...es the Company to have a minimum of $2,500,000 in ...of listed securities, or $500,000 of net income fr...
...eoGenomics, Inc. (NASD OTC Bulletin Board: NGNM), ...ng laboratories, today announced its results for t... 2008. , , Fourth Quarter 2008 Highlights: ...ase of 56% year-over-year from Q4 07 , 17.... 08 , Avg. Rev/Requisition increased 13.7%...
Other Biology Technology:GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 3Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 4NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 2NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 3NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 4NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 5NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 6NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 7NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 8
Cell Proliferation Kit from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Dysadherin 2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Trx-2 Monoclonal Antibody, Unconjugated, Clone 71G4 from Santa Cruz Biotechnology, Inc.
Biology Products: